Alfred Schweikert, PhD

Sr Vice President of Regulatory Affairs
Enalare Therapeutics
Princeton, New Jersey

Presentation(s):

• Poster Number-59 - The Agnostic Respiratory Stimulant ENA-001 Demonstrates Preliminary Positive Results in an Animal Model of Apnea of Prematurity

  Poster Abstracts